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ABSTRACT Int J infect Dis 1997; 2:9-11. 
Objective: To determine the etiology and outcome of adult bac- 
terial meningitis in Yaounde, Cameroon. 
Methods: Adult patients admitted for bacterial meningitis into 
the Yaounde Central Hospital between January 1988 and 
December 1993 were included in a retrospective review. Patient 
records were examined and information regarding etiology and 
outcome and relevant clinical and laboratory data were collected. 
Results: Seventy patients were included in the study. There 
were 41 men and 29 women; their ages ranged from 15 to 65 
years. Thirty patients had received antibiotic treatment before 
admission. Bacteriologic analysis of cerebrospinal fluid was 
performed in 46 patients, and a microbial etiology was estab- 
lished in 24 patients (34.3% of total). Streptococcus pneumo- 
niae and Neisseria meningitidis, were the most common 
organisms. Other isolates included fscherichia co/i, Salmonella 
enteritidis, Listeria monocytogenes, and Mycobacteria species; 
each of these species caused a single case of meningitis. Thirty 
patients (42.9%) had a complete clinical recovery, 18 patients 
(25.7%) developed sequelae, and 19 patients (27.1%) died. 
Ten patients died within 72 hours of admission. Three patients 
were taken out of the hospital by their families and were lost 
to follow-up. An age greater than 50 years was significantly 
associated with death (P < 0.05). Mortality was not related to 
etiology, although there was a trend toward increased mortal- 
ity with pneumococcal meningitis. 
Conclusion: The authors recommend that empirical treatment 
for bacterial meningitis should be given promptly and should 
cover S. pneumoniae and N. meningitidis, which are the most 
prevalent causes of bacterial meningitis in the community studied. 
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Bacterial meningitis remains a deadly disease world- 
wide. Despite the introductic I of newer antimicrobial 
agents and the tremendous knowledge gained about the 
pathogenesis of this disease, the mortality rate among 
adults with bacterial meningitis still ranges from 25 to 
45%.ls3 Early clinical recognition and prompt antibiotic 
treatment are the hallmark for survival from meningitis. 
Empirical antibiotic treatment should be given to limit 
mortality. The choice of antibiotic depends largely on 
the local bacterial epidemiology, the antimicrobial sus- 
ceptibility of these organisms, and the pharmacokinetics 
of available agents. Most published studies on the bac- 
terial etiology of meningitis, in developing countries, 
have focused on children. 4,5 The etiology of adult bac- 
terial meningitis has not been well documented. The 
objective of this study was to determine the etiology 
and outcome of adult bacterial meningitis in the local 
population. 
PATIENTS AND METHODS 
This study was conducted at the Infectious Disease Ser- 
vice of the Unit of Internal Medicine at Yaoundt Central 
HospitalThe authors reviewed the clinical records of all 
consecutive adult patients, aged 15 years and older, who 
were admitted between January 1988 and December 
1993 with bacterial meningitisThe bacterial etiology and 
outcome were recorded.The diagnosis of bacterial menin- 
gitis was based on clinical features such as headache, 
fever, nuchal rigidity, change in mental status (coma, agi- 
tation, restlessness, or delirium) associated with at least 
two of the following: (1) presence of turbid or purulent 
cerebrospinal fluid (CSE); (2) elevated CSF protein level 
over 1 g/L and glucose quotient CSF/blood or hypoglyc- 
orrhachia below 0.5 g/L; (3) CSF pleocytosis over 10 ele- 
ments/FL, with a predominance of polymorphonuclear 
leukocytes; and (4) presence of bacteria on Gram stain or 
culture of CSE 
Demographic data, antecedent or predisposing fac- 
tors, clinical signs and symptoms, laboratory analysis of 
CSF, blood cultures, antibiotic treatment before and after 
admission, duration of hospitalization and outcome, were 
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TABLE 1. Causes of Bacterial Meningitis in 46 Adults monocytogenes and Mycobacterium species caused 
Number of Cases meningitis in one case each (2.2%). 
Organism 
S. pneumoniae 
N. meningitidis 
E. co/i 
Salmonella species 
L. monocytogenes 
Mycobacterium species 
Culture negative 
n=46(%) 
14 (30.4) 
6 (13.0) 
1 (2.2) 
1 (2.2) 
1 (2.2) 
1 (2.2) 
22 (47.8) 
extracted from the patients’ files and were analyzed.Vari- 
ables were compared by chi-quare with significance level 
at P < 0.05. 
Antibiotic susceptibility studies were rarely per- 
formed because of costs.Thirty patients had received at 
least one dose of antibiotics before admission. Empirical 
antibiotic treatment was given to all 70 patients on admis- 
sion. It consisted of the combination of penicillin and 
chloramphenicol (55 patients) or aminopenicillin alone 
(10 patients) or combined with chloramphenicol (5 
patients). Parenteral therapy was continued, when pos- 
sible for 10 to 14 days. Chloramphenicol was discontin- 
ued if cultures yielded pneumococcus or meningococcus. 
The patient with mycobacterial meningitis was switched 
to triple oral antituberculosis therapy (isoniazid, rifampin, 
and pyrazinamide); pyrazinamide was continued for 2 
months and the other agents for 6 months. 
RESULTS 
Seventy patients were included in the study: 41 men and 
29 women, aged 15 to 65 years (mean, 34.3 y).All 70 
patients had fever (> 37.5”C) and 23 (32.9%) were in a 
comatose state on admission. Headache was observed in 
40 patients (57.1%) neck stiffness in 46 (65.7%), and vom- 
iting in 14 (20%). Factors predisposing to meningitis were 
not recorded in the majority of cases. One patient pre- 
sented with a CSF leak secondary to recent head trauma, 
one had sinusitis, and four patients had concurrent pneu- 
monia. For 24 of 70 patients, the diagnosis was mainly 
based on clinical presentation and purulent aspect 
(macroscopic and microscopic) of CSE For 46 patients, 
there was both clinical and CSF cytologic evidence of 
bacterial meningitis. Bacteriologic analyses of CSF were 
performed only in these 46 patients (65.7%). In 24 of 
them (52.2% of the subgroup), an etiologic agent was 
identified by culture. Blood cultures were performed in 
four patients, and only one was positive. 
The organisms recovered in CSF cultures are listed 
in Table 1. Streptococcus pneumoniae was the predom- 
inant etiologic agent and was responsible for meningitis 
in 14 of 46 (30.4%) patients who had CSF cultures. Neis- 
seria meningitidis was responsible for six (13%) cases, 
and Escherichia coli, Salmonella enteritidis, Listeria 
Table 2 shows the bacterial etiology and outcome of 
70 patients with purulent meningitis.Thirty of 70 patients 
(42.9%) experienced complete clinical recovery, 18 
patients (25.7%) developed sequelae, and 19 patients 
(27.1%) died during hospitalization. Ten of 19 patients 
died within 72 hours of admissionAnother three patients 
were taken out of the hospital by their families while in 
a comatose state and were lost to follow-up. Hearing 
impairment, confirmed by audiologic testing, and cranial 
nerve palsies were the most common sequelae; they were 
observed in ten and seven patients, respectivelyThe cause 
of meningitis was Spneumoniae in four of ten patients 
with hearing impairment, one of whom also had paraly- 
sis of the sixth cranial nerve. Neisseria meningitidis was 
responsible for cranial nerve palsy in two patients.The 
patient with tuberculous meningitis presented with ataxia 
and hearing loss, and the patient with listerial meningi- 
tis had speech disturbance. In 10 of 18 patients with 
sequelae, no causative organism was found. Hearing 
impairment (n = 5), cranial nerve palsy (n = 3, associated 
with right hemiparesis in 1 case), cerebral abscess 
(n = l), and hospital-acquired urinary tract infection due 
to Enterobacter aerogenes (n = 1) were among the com- 
plications observed in these patients. 
An age over 50 years was associated with a signifi- 
cantly higher mortality rate. The mortality rate was 17.5% 
Etiolosv 
TABLE 2. Bacterial Etiology, Complications, and Mortality in 70 Patients 
Number of Cases Complete Recovery Sequelae Deaths 
n = 70 (%)* n = 30 n= 18 n = 19 
Lost to Follow-up 
n=3 
S. pneumoniae 14 (58.3) 5 4 4 1 
N. meningitidis 6 (25.0) 3 2 1 0 
E. coli 1 (4.2) 0 0 1 0 
S. enteritidis 1 (4.2) 0 0 1 0 
L. monocytogenes 1 (4.2) 0 1 0 0 
Mycobacterium species 1 (4.2) 0 1 0 0 
Unknown etiology 46 22+ lO$ 12s 2n 
*Percentages calculated for 24 patients for whom an etiology was determined; +CSF was bacteriologically sterile in 9 patients and was not analyzed in 13 patients; 
*CSF was bacteriologically sterile in 8 patients, and in 2 patients CSF was not analyzed; SCSF was bacteriologically sterile in 4 patients and not analyzed in 8 patients: 
71 patient had bacteriologically sterile CSF, and in 1 patient CSF was not analyzed. 
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(10/57) among patients who were less than 50 years old 
versus 69.2% (y/13) among patients who were older than 
50 years (P = 0.01, x2 = 7.5, df = 1). 
The relation of CSF abnormalities to mortality could 
not be determined because the results of chemical 
analysis of CSF were available for only two of the patients 
who died and who had an established etiology. Strepto- 
coccus pneumoniae was isolated from 4 of 19 patients 
who died (21.1%). Of the 23 patients who were comatose 
on admission, 12 survived, 8 died, and 3 were lost to fol- 
low-up.There was no significant difference in the death 
rate among patients admitted with coma (S/23) com- 
pared with those without coma (1 l/47) on admission Q? 
= 0.47, x2 = 0.52) nor among patients with identified eti- 
ology (7/24) compared to those with unknown etiology 
(12/46). 
DISCUSSION 
This study identified the causative organisms of adult bac- 
terial meningitis in Yaounde Central Hospital, and it 
assessed outcomes of patients. However, etiologic agents 
of bacterial meningitis were determined in only 24 
(34.3%) of 70 patients due to the inability of many of the 
patients to pay for laboratory tests and also because some 
had received prior antibiotic treatment. Indeed, 30 
(42.9%) patients had received at least one dose of antibi- 
otic before admission. 
Streptococcus pneumoniae and NT meningitidis were 
the most common organisms, accounting for 58.3% and 
25% of known etiologies, respectively.This fmding agrees 
with that of other authors.‘,2 Gram-negative bacilli other 
than Haemophilus influenzae were recovered in two 
cases of meningitis, both of which were hospital acquired. 
Recurrent pneumococcal meningitis was observed in a 
patient with a history of head injury and CSF leak, and 
three patients with pneumococcal meningitis had con- 
current pneumonia. This finding is classic. The fourth 
patient with pneumonia had pulmonary tuberculosis and 
tuberculous meningitis. 
Hearing impairment and cranial nerve palsies were 
the most frequent complications in this study. Patients 
with pneumococcal meningitis were more prone to such 
complications. Hearing impairment has been documented 
in human and experimental bacterial meningitis,1~4~6 and 
different etiologies, including H. in$!uenzae have been 
incriminated as highly associated with deafness, particu- 
larly in children.’ Recently Dodge et al, in a prospective 
study, showed that deafness, which is a frequent compli- 
cation of bacterial meningitis, is more likely to follow 
pneumococcal meningitis.* 
The overall mortality rate in this study (27.1%) was 
lower than that of similar studies in other developing 
countries.3 High risk factors of death were an age over 
50 years (P < 0.01) and, probably, an infection with S. 
pneumoniae. This finding stresses the virulence of this 
organism and the need for its rapid treatment and its 
prevention in patients at risk of acquiring invasive pneu- 
mococcal disease. 
No difference in outcome was observed between the 
group of patients whose CSF yielded an etiologic agent 
and the two groups with unknown etiology (culture neg- 
ative CSF and unanalyzed CSF groups).Thus, it is probable 
that these two categories of patients shared the same 
kinds of etiologic factors. 
Although the laboratory of Yaounde Central Hospi- 
tal has the ability to perform microbiologic and bio- 
chemical analyses of CSF, the tests were not done, in many 
cases, because patients were unable to afford these ser- 
vices.Thus, the diagnosis of septic meningitis remained 
based on clinical symptoms and signs and the finding of 
turbid CSE 
The dependence on clinical signs and symptoms for 
diagnosis makes it critical to institute prompt empirical 
antibiotic treatment. The empirical regimen must cover 
S. pneumoniae and A? meningitidis, the most prevalent 
species, whenever clinical findings and macroscopic 
examination of the CSF are suggestive of bacterial menin- 
gitis. Penicillin remains the mainstay of treatment in devel- 
oping countries. Because of the increasing incidence of 
pneumococci resistant to penicillin worldwide, suscep- 
tibility studies of Spneumoniae to penicillin are urgently 
needed in Cameroon to guide the appropriate choice of 
empirical antibiotic therapy in bacterial meningitis. 
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